Market Overview: In 2022, the global gynecological drugs market reached a size of USD 15.34 Billion, and it is anticipated to exhibit a compound annual growth rate (CAGR) of 7.4% throughout the forecast period. Key drivers for this growth include the increasing incidence of gynecological cancer, growing health consciousness, rising investments in drug development, and advancements in drug manufacturing technology.
Request for Sample @https://www.reportsanddata.com/download-free-sample/6650
Cancer Statistics: The National Cancer Institute (NCI) projected 14,100 new cases of cervical cancer in the U.S. for 2022, reflecting a 0.7% increase from the previous year. Additionally, it estimated 4,280 deaths due to cervical cancer in the same period. Rising health awareness has led individuals to seek early diagnoses, fueling the demand for gynecological drugs globally.
Market Dynamics: Drivers: The prevalence of gynecological cancer, coupled with heightened research and development (R&D) activities, contributes significantly to market growth. The National Center for Biotechnology Information (NCBI) estimates millions of new cancer cases and deaths in China and the U.S., emphasizing the substantial demand for gynecological drugs. Advances in R&D, exemplified by initiatives like GlaxoSmithKline’s research on Zejula and Jemperli, further propel market growth.
Restraints: Safety concerns related to birth control pills and delays in drug approvals pose challenges. Despite widespread use, concerns persist about potential side effects, such as liver tumors, heart attacks, and strokes. Clinical trials also face obstacles, including efficacy issues, safety concerns, and funding limitations, impacting the overall growth of the market.
Key Insights: Therapeutics Outlook: The market is segmented into hormonal therapy and non-hormonal therapy. Hormonal therapy, addressing menopausal symptoms and gynecological disorders, is expected to dominate, driven by technological advancements and increased R&D.
Application Outlook: Gynecological cancers are anticipated to hold the largest revenue share due to a rise in cancer cases, heightened health awareness, and increased healthcare investments globally.
Distribution Channel: Online pharmacies are projected to register the highest revenue CAGR during the forecast period, attributed to factors such as cost-effectiveness, convenience, and diverse product availability.
Regional Insights:
- North America: Leads the market in 2022, driven by high breast cancer prevalence, postmenopausal disorders, and polycystic ovary syndrome. Initiatives like Illumigyn’s fundraising contribute to regional growth.
- Europe: Exhibits steady revenue growth, propelled by increased healthcare spending, rising R&D activities, and a surge in gynecological disorder cases. Collaborations, such as Evotec and Bayer’s partnership for PCOS medication development, contribute to market expansion.
- Asia Pacific: Anticipated to achieve the fastest revenue CAGR, supported by growing health awareness, government investments, and a high prevalence of women’s health disorders. Partnerships, like I’rom Group and Lupin’s collaboration for clinical trials in Japan, further drive regional growth.
Competitive Landscape: The market is fragmented and highly competitive, with players adopting strategies such as portfolio expansion, R&D, and strategic alliances. Major companies include Pfizer Inc., Johnson & Johnson Services, Inc., Abbott Laboratories, Novartis AG, and others. On April 7, 2022, Lupin launched Merzee pills in the U.S. to prevent pregnancy, further illustrating the dynamic competitive landscape.
Segments Covered in the Report:
- Therapeutics Outlook: Hormonal Therapy (Estrogen Therapy, Combination Therapy, Progestin Therapy, Thyroid Replacement Therapy, Parathyroid Hormone Therapy, Others), Non-Hormonal Therapy (Anti-Neoplastic Agents, Anti-Inflammatory Agents, Anti-Infective Agents, Others)
- Application Outlook: Gynecology Infections, Postmenopausal Disorders, Female Infertility, Contraception, Polycystic Ovary Syndrome, Endometriosis, Gynecological Cancers, Others
- Distribution Channel Outlook: Retail Pharmacy, Hospital Pharmacy, Online Pharmacy, Others
- Regional Outlook: North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Sweden, BENELUX, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Rest of APAC), Latin America (Brazil, Rest of LATAM), Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Israel, Rest of MEA)
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/6650
Thank you for reading global report. We also offer customized research reports as per client requirement. Kindly contact us for to know more about the feature and our team will provide you a well-curated report in the stipulated time.
Explore Trending Reports:
Dairy Testing Market-https://www.globenewswire.com/news-release/2020/03/23/2004931/0/en/Dairy-Testing-Market-To-Reach-USD-7-73-Billion-By-2026-Reports-and-Data.html
Eggshell Membrane Market-https://www.globenewswire.com/news-release/2020/08/10/2076041/0/en/Eggshell-Membrane-Market-To-Reach-USD-201-3-Million-By-2027-Reports-and-Data.html
Food Waste Management Market-https://www.globenewswire.com/news-release/2019/09/26/1921411/0/en/Food-Waste-Management-Market-To-Reach-USD-52195-6-Million-By-2026-Reports-And-Data.html
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a nconcrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release
About Author
